A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes

Inclusion Criteria: * Adults with type 2 diabetes as diagnosed by endocrinologist * No insulin over past 3 months * Inadequate glycemic control with A1c ≥8.0% at or within 1 month prior to screening visit * No history of diabetic ketoacidosis (DKA) or severe hypoglycemia leading to mental status change in the past 6 months * Willingness and ability to follow the protocol including willingness to commence basal insulin, wear CGM, and communicate with healthcare provider. Exclusion Criteria: * Contraindication to use of insulin glargine (e.g., allergy) * Impaired recognition of hypoglycemia by the participant (as judged by the investigator)